Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June ...

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the ...

Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...

Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston ...

The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of ...

Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend ...

The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...

Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and ...

CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it ...